Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Ann Oncol ; 31(1): 50-60, 2020 01.
Article in English | MEDLINE | ID: mdl-31912796

ABSTRACT

BACKGROUND: Immunotherapy agents are an innovative oncological treatment modality and as a result their use has expanded widely. Understanding the treatment-related adverse events (AEs) of these drugs compared with traditional chemotherapy is crucial for clinical practice. DESIGN: A systematic review of studies indexed in Medline (PubMed), Embase, Web of Science, and the Cochrane Databases from January 2000 to 14 February 2019 was conducted. Randomized clinical trials comparing immunotherapy [cytotoxic T-lymphocyte protein-4 (CTLA-4), programmed cell death protein 1 (PD-1), or programmed death-ligand 1 (PD-L1)] with standard-of-care chemotherapy in the treatment of advanced solid-organ neoplasms were included if AEs were reported as an outcome. Primary outcome was AEs ≥ grade 3 in severity. Secondary outcomes were proportion of overall AEs, treatment discontinuation due to AEs, deaths due to AEs, and specific AEs [fatigue, diarrhea, acute kidney injury (AKI), colitis, pneumonitis, and hypothyroidism]. Paule-Mandel pooling and a random effects model were used to produce odds ratios (ORs) for measures of effects. RESULTS: Among 10 598 abstracts screened, we included 22 studies involving 12 727 patients. In the immunotherapy group, 16.5% of patients developed an AE ≥ grade 3 in severity, compared with 41.09% in the chemotherapy arm [OR = 0.26, 95% confidence interval (CI) 0.19-0.35, I2 = 92%]. Patients receiving immunotherapy also had lower odds of developing an AE overall (OR = 0.35, 95% CI 0.28-0.44; I2 = 77%), terminating therapy due to an AE (OR = 0.55, 95% CI 0.39-0.78, I2 = 80%), or dying from a treatment-related AE (OR = 0.67, 95% CI 0.46-0.98, I2 = 0%). When treated with chemotherapy versus immunotherapy, patients more frequently experienced fatigue (25.10% versus 15.83%), diarrhea (14.97% versus 11.13%), and AKI (1.79% versus 1.31%). However, colitis (1.02% versus 0.26%), pneumonitis (3.36% versus 0.36%), and hypothyroidism (6.82% versus 0.37%) were more common in those treated with immunotherapy. CONCLUSIONS: Treatment of advanced solid-organ malignancies with immunotherapy compared with traditional chemotherapy is associated with a lower risk of AEs.


Subject(s)
Antineoplastic Agents , Neoplasms , Antineoplastic Agents/therapeutic use , Humans , Immunologic Factors/therapeutic use , Immunotherapy/adverse effects , Neoplasms/drug therapy , Randomized Controlled Trials as Topic
2.
West Indian Med J ; 63(1): 81-7, 2014 Jan.
Article in English | MEDLINE | ID: mdl-25303200

ABSTRACT

OBJECTIVE: Medical student research involvement has evolved to be a core component of medical education and is becoming increasingly vital to success in the United States residency match. We sought to develop a research website allowing students and research faculty to collaborate and complete projects online. METHODS: The Medical Student Research Institute (MSRI) was developed by the St George's University School of Medicine in 2009 to encourage, support, facilitate and centralize medical student research. RESULTS: There are 63 active students in the MSRI (22 students in basic science and 41 students in clinical rotations). The mean GPA for basic science student members was 3.81 ± 0.27 and was 3.80 ± 0.20 for clinical student members. The mean United States Medical Licensing Examination (USMLE) Step 1 score was 241.6 ± 17.5. Since 2009, MSRI students have published 87 manuscripts in 33 different journals and have presented at 14 different national and international conferences. CONCLUSION: A web-based MSRI provides a virtual, entirely online resource for coordinating remote research collaboration between medical students and faculty whose opportunities would be otherwise limited. Initial experiences with the programme have been positive and the framework and concept of the MSRI provides a platform for university and medical schools to provide research opportunities to students who may not have face-to-face access to research faculty.

3.
West Indian med. j ; 63(1): 81-87, Jan. 2014. ilus, tab
Article in English | LILACS | ID: biblio-1045792

ABSTRACT

OBJECTIVE: Medical student research involvement has evolved to be a core component of medical education and is becoming increasingly vital to success in the United States residency match. We sought to develop a research website allowing students and research faculty to collaborate and complete projects online. METHODS: The Medical Student Research Institute (MSRI) was developed by the St George's University School of Medicine in 2009 to encourage, support, facilitate and centralize medical student research. RESULTS: There are 63 active students in the MSRI (22 students in basic science and 41 students in clinical rotations). The mean GPA for basic science student members was 3.81 ± 0.27 and was 3.80 ± 0.20 for clinical student members. The mean United States Medical Licensing Examination (USMLE) Step 1 score was 241.6 ± 17.5. Since 2009, MSRI students have published 87 manuscripts in 33 different journals and have presented at 14 different national and international conferences. CONCLUSION: A web-based MSRI provides a virtual, entirely online resource for coordinating remote research collaboration between medical students and faculty whose opportunities would be otherwise limited. Initial experiences with the programme have been positive and the framework and concept of the MSRI provides a platform for university and medical schools to provide research opportunities to students who may not have face-to-face access to research faculty.


OBJETIVO: La participación estudiantil en la investigación médica ha evolucionado hasta llegar a ser un componente esencial de la educación médica, y se está convirtiendo cada vez más en un elemento vital para el éxito en obtener una plaza en los programas de residencia de medicina en los Estados Unidos. Buscamos desarrollar un sitio web de investigación que permita a los estudiantes y profesores de investigación colaborar y realizar proyectos online. MÉTODOS: El Instituto de Investigación Médica Estudiantil (MSRI por sus siglas en inglés) fue desarrollado por la Escuela de Medicina de la Universidad de Saint George en 2009 para estimular, apoyar, facilitar y centralizar la investigación médica estudiantil. RESULTADOS: Hay 63 estudiantes activos en el MSRI (22 estudiantes en ciencias básicas y 41 estudiantes en rotaciones clínicas). El promedio general de calificaciones (PGC) de los miembros estudiantes de ciencias básicas fue 3.81 ± 0.27, y el de los miembros estudiantes clínicos fue 3.80 ± 0.20. La puntuación promedio obtenida en el primer paso del Examen de Licencia Médica de los Estados Unidos (USMLE, en inglés) fue 241.6 ± 17.5. Desde 2009, los estudiantes del MSRI han publicado 87 manuscritos en 33 diferentes revistas, y han presentado trabajos en 14 conferencias nacionales e internacionales. CONCLUSIÓN: Un MSRI basado en la red de la Internet proporciona un recurso virtual, totalmente online, que permite coordinar la colaboración a distancia entre estudiantes y profesores de medicina, quienes de lo contrario verían limitadas sus oportunidades. Las experiencias iniciales con el programa han sido positivas. El marco y los conceptos del MSRI proporciona una plataforma para que la Universidad y las escuelas de medicina puedan brindar oportunidades de investigación a los estudiantes que no tengan acceso presencial a la Facultad de investigación.


Subject(s)
Humans , Male , Female , Students, Medical , User-Computer Interface , Biomedical Research/education , Education, Medical, Undergraduate , Virtual Reality
4.
Prostate Cancer Prostatic Dis ; 16(4): 387-90, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24100643

ABSTRACT

BACKGROUND: There is emerging data suggesting a potential risk for meningioma growth stimulation in patients on luteinizing hormone-releasing hormone (LHRH) analogs for prostate cancer. We examined the expression of LHRH receptor (LHRH-R), progesterone receptor (PR) and Ki67 labeling index (LI) in specimens from male meningioma (MM) and female meningioma (FM) patients. METHODS: A total of 24 MM and 24 FM paraffin blocks were retrieved from our institution between 1991 and 2008. Sections from the paraffin blocks were stained with mouse monoclonal antibodies against LHRH-R, PR and Ki67. All male patients had no previous history of prostate cancer (PCa) or previous history of hormone therapy. RESULTS: LHRH-R positivity was extensive in 92% of MM and 88% of FM samples, with both showing strong intensity (67% and 79%, respectively). PR was positive in 20 of 24 (83%) MM and 23 of 24 (96%) FM samples. MM is less likely to exhibit Ki67 LI >4% compared with FM. CONCLUSIONS: The majority of MM and FM samples were strongly positive for LHRH-R expression and PR expression. The emerging association of androgen deprivation therapy and meningioma growth should be recognized in urological practice. Caution should be taken when considering LHRH agonist administration for patients with PCa and concurrent meningioma or previous history of meningioma.


Subject(s)
Androgen Antagonists/adverse effects , Antineoplastic Agents, Hormonal/adverse effects , Meningioma/etiology , Neoplasms, Second Primary/etiology , Androgen Antagonists/therapeutic use , Antineoplastic Agents, Hormonal/therapeutic use , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Ki-67 Antigen/genetics , Ki-67 Antigen/metabolism , Male , Meningioma/genetics , Neoplasms, Second Primary/genetics , Prostatic Neoplasms/drug therapy , Receptors, LHRH/genetics , Receptors, LHRH/metabolism , Receptors, Progesterone/genetics , Receptors, Progesterone/metabolism , Sex Factors
5.
Prostate Cancer Prostatic Dis ; 16(4): 376-81, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24018710

ABSTRACT

BACKGROUND: Agent Orange (AO) was previously identified as a significant risk factor for biochemical recurrence (BCR) after radical prostatectomy (RP) in prostate cancer patients. In this study, we determined the levels of dioxin biological toxicity using toxic equivalency (TEQ) values and examined the impact of dioxin-TEQ level on BCR. METHODS: A total of 93 men who underwent RP, with a median of 5.3 years of postoperative follow-up, were included in the study. The dioxin-TEQ level of each patient was measured using intraoperatively harvested abdominal subcutaneous fat. The dichotomous categorization of dioxin-TEQ by the 50th percentile (low<50% vs high 50%) was also used to regroup the patient cohort, regardless of the previous history of AO exposure. Comparisons between the dioxin-TEQ levels, clinicopathological characteristics and BCR in AO-exposed and -unexposed men were made to allocate possible risk factors. The multivariable logistic regression model was used to identify significant risk factors associated with BCR, adjusting for other confounding factors. RESULTS: The median dioxin-TEQ level in 37 AO-exposed patients was significantly higher than that in 56 unexposed patients (22.3 vs 15.0 pg g(-1) fat, respectively, P<0.001). The men with AO exposure were more likely to have a high dioxin-TEQ level (P<0.001). Neither AO exposure nor the level of dioxin-TEQ was associated with BCR. Tumor stage (T3/T4 vs T2) and Gleason grade (Gleason 3+4) were independent risk factors for BCR after RP. CONCLUSIONS: Exposure to AO significantly increases the adipose level of dioxin-TEQ in patients treated with RP. However, exposure to AO or a high dioxin-TEQ level was not associated with an increased risk of BCR after RP. This lack of association supports the current conclusion that the evidence of carcinogenicity of AO in prostate cancer patients is not sufficient and remains 'limited'.


Subject(s)
2,4,5-Trichlorophenoxyacetic Acid/adverse effects , 2,4-Dichlorophenoxyacetic Acid/adverse effects , Dioxins/adverse effects , Polychlorinated Dibenzodioxins/adverse effects , Prostatic Neoplasms/etiology , Prostatic Neoplasms/pathology , 2,4,5-Trichlorophenoxyacetic Acid/chemistry , 2,4-Dichlorophenoxyacetic Acid/chemistry , Agent Orange , Biopsy , Dioxins/chemistry , Environmental Exposure/adverse effects , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Neoplasm Staging , Polychlorinated Dibenzodioxins/chemistry , Prostate/drug effects , Prostate/pathology , Prostate/surgery , Prostate-Specific Antigen/blood , Prostatectomy , Prostatic Neoplasms/surgery , Risk Factors , Time Factors
6.
Folia Morphol (Warsz) ; 66(4): 272-6, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18058747

ABSTRACT

Popliteal artery aneurysms (PAAs) are the most common form of peripheral arterial aneurysms. The popliteal artery is the continuation of the femoral artery and represents the major source of blood to the leg. Thrombus formation as a result of PAA may reduce blood flow, leading to limb-threatening ischemia and potential limb amputation. Popliteal artery aneurysms are predominantly seen in males (95-99% of cases), presumably owing to their predisposition for arteriosclerosis, which is also a major factor for PAA predisposition. Additionally, it is not uncommon to see an abdominal aortic aneurysm associated with a PAA (30-50% of cases) or bilateral presentation of PAA (approximately 50% of cases). A consequence of a PAA and thrombus located in the popliteal fossa is an inflammatory reaction, potentially involving adjacent structures in the fossa. This may present clinically as pain in the leg and/or edema. Treatment of PAA involves either a conservative management protocol or a more aggressive intervention such as surgery. Proponents of conservative management will regulate the diameter of the aneurysm by ultrasound, while those in favor of surgical intervention will repair the aneurysm through a number of open surgical methods or by endovascular stent grafting. This review summarizes the historical points related to PAA and analyzes the pertinent anatomical implications, clinical findings and treatment methods for PAA.


Subject(s)
Aneurysm/etiology , Aneurysm/pathology , Popliteal Artery/pathology , Popliteal Artery/physiopathology , Aneurysm/therapy , Aortic Aneurysm, Abdominal/complications , Aortic Aneurysm, Abdominal/physiopathology , Arteriosclerosis/complications , Female , Humans , Lithotripsy/standards , Male , Popliteal Artery/surgery , Sex Factors , Stents/standards , Thrombosis/complications , Thrombosis/physiopathology , Vascular Surgical Procedures/methods , Vascular Surgical Procedures/standards , Vasculitis/complications , Vasculitis/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...